Too few cancer patients who have a heart attack are receiving emergency angioplasties that could save their lives, a new study finds.
"This is an important study, which underscores the broader issue in cardio-oncology of cancer patients too often being passed over for potentially beneficial procedures," said Dr. Robert Copeland-Halperin, a cardiologist unconnected to the new research.
Ernie Mundell and Robert Preidt HealthDay Reporters
A pair of studies shed new light on why a relatively rare blood cancer — acute myeloid leukemia (AML) — is more deadly among Black patients.
The takeaways: Where patients live and their access to quality health care matter. And even when Black people with AML have the same access to treatment as white patients, their survival is shorter — something genetic differences might explain....
Cancer survivors have higher odds of dying from seasonal flu, suggesting they may also be at increased risk from COVID-19 and may need to be among the first in line for vaccination against both diseases.
Researchers from the London School of Hygiene & Tropical Medicine analyzed medical data from more than 630,000 people in the United Kingdom between 1990 and 2014, including more than 10...
A combination of two "targeted" therapies can beat back a rare form of blood cancer -- without the toxic effects of chemotherapy, a new study has found.
In a trial of 63 patients, researchers found that the drug regimen frequently wiped out all signs of the cancer -- a subtype of the blood cancer acute lymphoblastic leukemia (ALL). And at 18 months, 95% of patients were still aliv...
A drug used to fight chronic myeloid leukemia might also relieve symptoms of Parkinson's disease, a new study finds.
In a phase 2 clinical trial, researchers found that the drug nilotinib (brand name: Tasigna) increased production of dopamine and halted decline in motor function. It was well-tolerated by most participants.
"We found that nilotinib is reasonably safe using d...
Boosting exercise capacity may protect the mental functioning of childhood leukemia survivors, according to a new study.
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Due to their disease and treatment, childhood ALL survivors are at increased risk for problems with thinking and memory, as well as reduced exercise capacity, researchers said.
If a close relative has had blood cancer, you're more likely to get it, a large new study reports.
The researchers analyzed data from 16 million people in Sweden, including more than 153,000 diagnosed with blood cancer and more than 391,000 of their first-degree relatives: parents, siblings or children.
Patients with a family link accounted for 4.1% of all blood cancer ...
More than 8.7 million years of life and about $94 billion in earnings were lost to cancer in the United States in 2015, researchers say.
Cancer is the nation's second-leading killer and is expected to cause nearly 607,000 deaths this year. These premature deaths and the lost productivity they cause impose a significant economic burden, the study authors explained.
The chances of finding an unrelated bone marrow donor are higher for U.S. patients of European descent than for those of non-European descent, a new study finds.
A bone marrow transplant can sometimes help people with life-threatening blood cancers by replacing the patient's cells with healthy ones from a donor. A brother or sister with the same genetic markers as the recipient is the...